
    
      Evaluation Criteria:

        -  Primary outcome Pharmacodynamic assessments using P2Y12 assay

        -  Secondary outcome Pharmacokinetics assessments on Cmax,ss, AUCÏ„,ss, tmax,ss, Cmin,ss ,
           CLss/F of Clopidogrel

        -  Safety assessments with adverse event monitoring including subjective/objective
           symptoms, physical examination, vital signs, electrocardiogram, and laboratory test
    
  